257 related articles for article (PubMed ID: 26391917)
1. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.
Petrick JL; Sahasrabuddhe VV; Chan AT; Alavanja MC; Beane-Freeman LE; Buring JE; Chen J; Chong DQ; Freedman ND; Fuchs CS; Gaziano JM; Giovannucci E; Graubard BI; Hollenbeck AR; Hou L; Jacobs EJ; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Purdue MP; Rosenberg L; Schairer C; Sesso HD; Sigurdson AJ; Wactawski-Wende J; Zeleniuch-Jacquotte A; Campbell PT; McGlynn KA
Cancer Prev Res (Phila); 2015 Dec; 8(12):1156-62. PubMed ID: 26391917
[TBL] [Abstract][Full Text] [Related]
2. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.
Petrick JL; Campbell PT; Koshiol J; Thistle JE; Andreotti G; Beane-Freeman LE; Buring JE; Chan AT; Chong DQ; Doody MM; Gapstur SM; Gaziano JM; Giovannucci E; Graubard BI; Lee IM; Liao LM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Rosenberg L; Schairer C; Sesso HD; Sinha R; Stampfer MJ; Stefanick M; Wactawski-Wende J; Zhang X; Zeleniuch-Jacquotte A; Freedman ND; McGlynn KA
Br J Cancer; 2018 Apr; 118(7):1005-1012. PubMed ID: 29520041
[TBL] [Abstract][Full Text] [Related]
3. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.
Petrick JL; Freedman ND; Graubard BI; Sahasrabuddhe VV; Lai GY; Alavanja MC; Beane-Freeman LE; Boggs DA; Buring JE; Chan AT; Chong DQ; Fuchs CS; Gapstur SM; Gaziano JM; Giovannucci EL; Hollenbeck AR; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Schairer C; Sesso HD; Sigurdson AJ; Zeleniuch-Jacquotte A; Wactawski-Wende J; Campbell PT; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1398-406. PubMed ID: 26126626
[TBL] [Abstract][Full Text] [Related]
4. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project.
Florio AA; Campbell PT; Zhang X; Zeleniuch-Jacquotte A; Wactawski-Wende J; Smith-Warner SA; Sinha R; Simon TG; Sesso HD; Schairer C; Rosenberg L; Rohan TE; Robien K; Renehan AG; Purdue MP; Poynter JN; Palmer JR; Newton CC; Lu Y; Linet MS; Liao LM; Lee IM; Koshiol J; Kitahara CM; Kirsh VA; Hofmann JN; Graubard BI; Giovannucci E; Gaziano JM; Gapstur SM; Freedman ND; Demuth J; Chong DQ; Chan AT; Buring JE; Bradshaw PT; Beane Freeman LE; McGlynn KA; Petrick JL
Int J Cancer; 2020 Aug; 147(3):675-685. PubMed ID: 31677159
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
[TBL] [Abstract][Full Text] [Related]
6. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
[TBL] [Abstract][Full Text] [Related]
7. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis.
Petrick JL; Thistle JE; Zeleniuch-Jacquotte A; Zhang X; Wactawski-Wende J; Van Dyke AL; Stampfer MJ; Sinha R; Sesso HD; Schairer C; Rosenberg L; Rohan TE; Robien K; Purdue MP; Poynter JN; Palmer JR; Newton CC; Linet MS; Liao LM; Lee IM; Koshiol J; Kitahara CM; Hofmann JN; Graubard BI; Giovannucci E; Gaziano MJ; Gapstur SM; Freedman ND; Chong DQ; Chan AT; Buring JE; Freeman LBE; Campbell PT; McGlynn KA
Am J Gastroenterol; 2018 Oct; 113(10):1494-1505. PubMed ID: 30177781
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.
Erichsen R; Olén O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):886-894. PubMed ID: 33627380
[TBL] [Abstract][Full Text] [Related]
9. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
McGlynn KA; Tarone RE; El-Serag HB
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1198-203. PubMed ID: 16775181
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
[TBL] [Abstract][Full Text] [Related]
11. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
[TBL] [Abstract][Full Text] [Related]
12. Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.
Yang B; Petrick JL; Kelly SP; Graubard BI; Freedman ND; McGlynn KA
Int J Cancer; 2017 Jul; 141(2):271-278. PubMed ID: 28411388
[TBL] [Abstract][Full Text] [Related]
13. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
Tan RZH; Lockart I; Abdel Shaheed C; Danta M
Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
Hwang IC; Chang J; Kim K; Park SM
Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
[TBL] [Abstract][Full Text] [Related]
15. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
El-Serag HB; Engels EA; Landgren O; Chiao E; Henderson L; Amaratunge HC; Giordano TP
Hepatology; 2009 Jan; 49(1):116-23. PubMed ID: 19085911
[TBL] [Abstract][Full Text] [Related]
16. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
18. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
[TBL] [Abstract][Full Text] [Related]
19. Exogenous hormone use, reproductive factors and risk of intrahepatic cholangiocarcinoma among women: results from cohort studies in the Liver Cancer Pooling Project and the UK Biobank.
Petrick JL; McMenamin ÚC; Zhang X; Zeleniuch-Jacquotte A; Wactawski-Wende J; Simon TG; Sinha R; Sesso HD; Schairer C; Rosenberg L; Rohan TE; Robien K; Purdue MP; Poynter JN; Palmer JR; Lu Y; Linet MS; Liao LM; Lee IM; Koshiol J; Kitahara CM; Kirsh VA; Hofmann JN; Graubard BI; Giovannucci E; Gaziano JM; Gapstur SM; Freedman ND; Florio AA; Chong DQ; Chen Y; Chan AT; Buring JE; Freeman LEB; Bea JW; Cardwell CR; Campbell PT; McGlynn KA
Br J Cancer; 2020 Jul; 123(2):316-324. PubMed ID: 32376888
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Massarweh NN; El-Serag HB
Cancer Control; 2017; 24(3):1073274817729245. PubMed ID: 28975830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
